Tech Company Financing Transactions

IntegenX Funding Round

Square 1 Bank joined a $5 million capital raise for IntegenX. The funding round was announced on 12/21/2011.

Transaction Overview

Company Name
Announced On
12/21/2011
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors

Square 1 Bank (Scott Foote)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5720 Stoneridge Dr. 300
Pleasanton, CA 94588
USA
Email Address
Overview
Rapid DNA for Human Identification, Rapid NGS Library Preparation, and Nucleic Acid Stabilization. IntegenX Corporate Information, Events, and Product News.
Profile
IntegenX LinkedIn Company Profile
Social Media
IntegenX Company Twitter Account
Company News
IntegenX News
Facebook
IntegenX on Facebook
YouTube
IntegenX on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Schueren
  Robert Schueren LinkedIn Profile  Robert Schueren Twitter Account  Robert Schueren News  Robert Schueren on Facebook
Chief Operating Officer
David Smith
  David Smith LinkedIn Profile  David Smith Twitter Account  David Smith News  David Smith on Facebook
VP - Product Management
David King
  David King LinkedIn Profile  David King Twitter Account  David King News  David King on Facebook
VP - Sales
Jay Therrien
  Jay Therrien LinkedIn Profile  Jay Therrien Twitter Account  Jay Therrien News  Jay Therrien on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/21/2011: ScaleArc venture capital transaction
Next: 12/21/2011: Presidio Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary